Clinical efficacy and safety of topical treatment of atopic dermatitis

Por N. V. Kungurov, M. M. Kokhan, Y. V. Koenigsfest
Publicado em 2013-12-01

Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis

Por A. A. Kubanov, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, E. V. Sokolovskiy, M. M. Kokhan, A. V. Artemyeva, E V. Chernyaeva, R. A. Ivanov
Publicado em 2019-07-01

Draft interdisciplinary guidelines for diagnosis, methods for estimation of the degree of activity, for evaluation of therapeutic efficacy, and for use of biological agents in pati...

Por D. I. Abdulganieva, A. L. Bakulev, E. А. Belousova, L. F. Znamenskaya, T. V. Korotaeva, L. S. Kruglova, M. M. Kokhan, A. M. Lila, V. R. Khairutdinov, I. L. Khalif, M. M. Khobeish
Publicado em 2018-09-01

Comparative efficacy and safety of adalimumab biosimilar (BCD-057) and innovator in patients with psoriasis vulgaris. Results of the BCD-057-2/CALYPSO phase III international, mult...

Por Т. V. Korotaeva, A. V. Samtsov, A. L. Bakulev, M. M. Kokhan, I. K. Minullin, O. A. Vylegzhanina, V. V. Dubensky, B. V. Khalilov, A. A. Khotko, O. S. Zykova, I. V. Chumachenko, A. M. Lukyanov, A. V. Artemyeva, S. I. Derbin, E. Yu. Stukalina, E. V. Chernyaeva, R. A. Ivanov
Publicado em 2018-12-01